Athalia R. Pyzer

1.1k total citations
23 papers, 398 citations indexed

About

Athalia R. Pyzer is a scholar working on Oncology, Immunology and Infectious Diseases. According to data from OpenAlex, Athalia R. Pyzer has authored 23 papers receiving a total of 398 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 9 papers in Immunology and 7 papers in Infectious Diseases. Recurrent topics in Athalia R. Pyzer's work include SARS-CoV-2 and COVID-19 Research (5 papers), COVID-19 Clinical Research Studies (5 papers) and Lymphoma Diagnosis and Treatment (4 papers). Athalia R. Pyzer is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (5 papers), COVID-19 Clinical Research Studies (5 papers) and Lymphoma Diagnosis and Treatment (4 papers). Athalia R. Pyzer collaborates with scholars based in United States, Italy and Germany. Athalia R. Pyzer's co-authors include David Avigan, Jacalyn Rosenblatt, Leandra Cole, Dina Stroopinsky, Eleni Anastasiadou, Frank J. Slack, Christopher S. Chen, Stefania Uccini, Alan Jiao and Martina Severa and has published in prestigious journals such as Blood, Cancer Research and Clinical Cancer Research.

In The Last Decade

Athalia R. Pyzer

20 papers receiving 394 citations

Peers

Athalia R. Pyzer

IMMUN

ONCOL

HEMAT

Jovian Yu United States

Ron D. Jachimowicz Germany

Shriram K. Sundararaman United States

Alessandra Jales United States

Nadine Kutsch Germany

Lucia Mundo Italy

Dmitry Pankov United States

Sabrina Carpentier France

Shunsuke Kimura Japan

Ashley Ambrose United Kingdom

Jovian Yu United States

Athalia R. Pyzer

216 ×1.1

IMMUN

232 ×1.3

ONCOL

173 ×1.1

61 ×1.0

43 ×0.8

HEMAT

Citations per year, relative to Athalia R. Pyzer Athalia R. Pyzer (= 1×) peers Jovian Yu

Countries citing papers authored by Athalia R. Pyzer

Since Specialization

Citations

This map shows the geographic impact of Athalia R. Pyzer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Athalia R. Pyzer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Athalia R. Pyzer more than expected).

Fields of papers citing papers by Athalia R. Pyzer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Athalia R. Pyzer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Athalia R. Pyzer. The network helps show where Athalia R. Pyzer may publish in the future.

Co-authorship network of co-authors of Athalia R. Pyzer

This figure shows the co-authorship network connecting the top 25 collaborators of Athalia R. Pyzer. A scholar is included among the top collaborators of Athalia R. Pyzer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Athalia R. Pyzer. Athalia R. Pyzer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rouhani, Sherin J., Jovian Yu, Daniel J. Olson, et al.. (2022). Antibody and T cell responses to COVID-19 vaccination in patients receiving anticancer therapies. Journal for ImmunoTherapy of Cancer. 10(6). e004766–e004766. 8 indexed citations

Briquez, Priscilla S., Sherin J. Rouhani, Jovian Yu, et al.. (2022). Severe COVID-19 induces autoantibodies against angiotensin II that correlate with blood pressure dysregulation and disease severity. Science Advances. 8(40). eabn3777–eabn3777. 31 indexed citations

Higgs, Emily F., Blake Flood, Athalia R. Pyzer, et al.. (2022). Insights from a Rapidly Implemented COVID-19 Biobank Using Electronic Consent and Informatics Tools. Biopreservation and Biobanking. 21(2). 166–175.

Gurbuxani, Sandeep, Jeffrey Mueller, Aliya N. Husain, et al.. (2022). Lymphatic coagulation and neutrophil extracellular traps in lung-draining lymph nodes of COVID-19 decedents. Blood Advances. 6(24). 6249–6262. 13 indexed citations

Cabanov, Alexandra, Blake Flood, Jeffrey Bloodworth, et al.. (2020). Treatment with tocilizumab does not inhibit induction of anti-COVID-19 antibodies in patients with severe SARS-CoV-2 infection. Clinical Cancer Research. 26(18).

Cabanov, Alexandra, Blake Flood, Jeffrey Bloodworth, et al.. (2020). Abstract S04-02: Treatment with tocilizumab does not inhibit induction of anti-COVID-19 antibodies in patients with severe SARS-CoV-2 infection. Clinical Cancer Research. 26(18_Supplement). S04–2. 1 indexed citations

Anastasiadou, Eleni, Dina Stroopinsky, Stella Alimperti, et al.. (2018). Epstein−Barr virus-encoded EBNA2 alters immune checkpoint PD-L1 expression by downregulating miR-34a in B-cell lymphomas. Leukemia. 33(1). 132–147. 129 indexed citations

Anastasiadou, Eleni, Dina Stroopinsky, Stella Alimperti, et al.. (2018). Abstract A16: Epstein-Barr virus encoded EBNA2 alters immune checkpoint PD-L1 expression by downregulating miR-34a in B cell lymphomas. Cancer Immunology Research. 6(9_Supplement). A16–A16. 1 indexed citations

Jain, Salvia, Abigail Washington, Rebecca Karp Leaf, et al.. (2017). Decitabine Priming Enhances Mucin 1 Inhibition Mediated Disruption of Redox Homeostasis in Cutaneous T-Cell Lymphoma. Molecular Cancer Therapeutics. 16(10). 2304–2314. 10 indexed citations

10.

Bar‐Natan, Michal, Dina Stroopinsky, Katarina Luptakova, et al.. (2017). Bone marrow stroma protects myeloma cells from cytotoxic damage via induction of the oncoprotein MUC1. British Journal of Haematology. 176(6). 929–938. 23 indexed citations

11.

Leaf, Rebecca Karp, Dina Stroopinsky, Athalia R. Pyzer, et al.. (2017). DCOne as an Allogeneic Cell-based Vaccine for Multiple Myeloma. Journal of Immunotherapy. 40(9). 315–322. 16 indexed citations

12.

Stroopinsky, Dina, Athalia R. Pyzer, Eleni Anastasiadou, et al.. (2017). Abstract 54: MUC1-C regulates PD-L1 expression in acute myeloid leukemia, via downregulation of miRNAs. Clinical Cancer Research. 23(24_Supplement). 54–54. 2 indexed citations

13.

Jain, Salvia, Abigail Washington, Rebecca Karp Leaf, et al.. (2016). Decitabine Priming Enhances Mucin 1 Inhibition Mediated Disruption of Redox Homeostasis in Cutaneous T-Cell Lymphoma. Blood. 128(22). 4175–4175. 1 indexed citations

14.

Pyzer, Athalia R., Dina Stroopinsky, Jacalyn Rosenblatt, et al.. (2016). MUC1-C Inhibition Leads to Decrease in PD-L1 Levels Via up-Regulation of Micro RNAs. Blood. 128(22). 2871–2871. 2 indexed citations

15.

Pyzer, Athalia R., Leandra Cole, Jacalyn Rosenblatt, & David Avigan. (2016). Myeloid‐derived suppressor cells as effectors of immune suppression in cancer. International Journal of Cancer. 139(9). 1915–1926. 80 indexed citations

16.

Jain, Salvia, Dina Stroopinsky, Yin Li, et al.. (2015). Mucin 1 is a potential therapeutic target in cutaneous T-cell lymphoma. Blood. 126(3). 354–362. 28 indexed citations

17.

Nahas, Myrna, Dina Stroopinsky, Hasan Rajabi, et al.. (2015). MUC1 Inhibition Overcomes Chemotherapy Resistance in Acute Myeloid Leukemia. Blood. 126(23). 2473–2473. 2 indexed citations

18.

Patnaik, Akash, Kenneth D. Swanson, Katja Helenius, et al.. (2015). Abstract 5497: Cabozantinib eradicates de novo castrate-resistant PTEN/p53 deficient murine prostate cancer via activation of neutrophil-mediated anti-tumor innate immunity. Cancer Research. 75(15_Supplement). 5497–5497. 1 indexed citations

19.

Pyzer, Athalia R., David Avigan, & Jacalyn Rosenblatt. (2014). Clinical trials of dendritic cell-based cancer vaccines in hematologic malignancies. Human Vaccines & Immunotherapeutics. 10(11). 3125–3131. 44 indexed citations

20.

Pyzer, Athalia R.. (2010). An American revolution?. BMJ. c1041–c1041. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact